Skip to main navigation Skip to search Skip to main content

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB

  • Arm R. Amin
  • , Fadlo R. Khuri
  • , Zhuo (Georgia) Chen
  • , Doug M. Shin

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmaceutical Science and Research
StatePublished - Jun 1 2009

Keywords

  • Chemoprevention
  • EGFR-TKI
  • molecular targets
  • p53

Disciplines

  • Medicinal and Pharmaceutical Chemistry
  • Medicine and Health Sciences
  • Pharmacy and Pharmaceutical Sciences

Cite this